Lixte Biotechnology Holdings, Inc. (LIXT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lixte Biotechnology Holdings, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -31.66x | -1.27x | -0.88x | -1.28x | -2.38x | -10.95x |
| P/B Ratio | 19.69x | 5.52x | 1.12x | 1.56x | 3.35x | 7.13x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.88x | 3.26x | 13.73x | 14.05x | 16.81x | 24.15x |
| Quick Ratio | 3.88x | 3.26x | 13.73x | 14.05x | 16.81x | 24.15x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..